Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P29
Within normal range
vs 3Y Ago
-0.6x
Contraction
Streak
4 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -18.75% |
| Q3 2025 | -2.84% |
| Q2 2025 | 8.99% |
| Q1 2025 | 10.21% |
| Q4 2024 | 10.99% |
| Q3 2024 | -132.41% |
| Q2 2024 | 332.69% |
| Q1 2024 | -8.94% |
| Q4 2023 | -1.15% |
| Q3 2023 | -9.49% |
| Q2 2023 | 13.62% |
| Q1 2023 | -22.59% |
| Q4 2022 | 29.66% |
| Q3 2022 | 1.81% |
| Q2 2022 | -28.33% |
| Q1 2022 | 0.11% |
| Q4 2021 | 2.45% |
| Q3 2021 | -24.77% |
| Q2 2021 | -11.51% |
| Q1 2021 | 18.77% |
| Q4 2020 | -341.55% |
| Q3 2020 | 67.92% |
| Q2 2020 | 9.13% |
| Q1 2020 | -242.62% |
| Q4 2019 | 65.21% |
| Q3 2019 | -7.61% |
| Q2 2019 | -20.46% |
| Q1 2019 | -3.42% |
| Q4 2018 | -95.58% |
| Q3 2018 | 45.23% |
| Q2 2018 | -24.25% |
| Q1 2018 | 0.00% |